Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study

NCT06472258 is registered in ClinicalTrials.gov with RESnTEC, Institute of Research as lead sponsor.

NCT NCT06472258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study
Lead sponsor
RESnTEC, Institute of Research
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2023
Completion date
June 30, 2023
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria